TrialResults - center   -  Clinical trials results database in cardiology oncology (not yet available)

GAMMA

You are here:  Home > Search and browse > Browse treatment 3

Overview of clinical data for liraglutide     pdf

Clinical trials of liraglutide (liraglutide, victoza) and the meta-analysis of their results are available for the following clinical conditions:

Diabetes

all type of patients (in overview of all insulin secretagogues peptides (incretins))    pdf

liraglutide vs glargine add on SU+MET :  LEAD-5 (vs Glargine) (unpublished)  - 
liraglutide vs glimepiride :  Madsbad (vs Glimepiride) ,2004  -  LEAD-3 mono (Garber) ,2009  - 
liraglutide vs glimepiride add on MET :  LEAD-2 (Nauck) (vs glimepiride) ,2009  - 
liraglutide vs metformin :  Feinglos ,2005  - 
liraglutide vs placebo :  Vilsboll ,2008  -  Seino ,2008  -  Madsbad (vs placebo) ,2004  - 
liraglutide vs placebo add on MET :  LEAD-2 (Nauck) (vs placebo) ,2009  - 
liraglutide vs placebo add on SU :  LEAD-1 (unpublished)  - 
liraglutide vs placebo add on SU+MET :  LEAD-5 (vs placebo) (unpublished)  - 
liraglutide vs placebo add on TZD+MET :  LEAD-4 (unpublished)  - 
liraglutide vs sitagliptine add on MET :  LEADER (ongoing)  - 

Obesity and overweight

all type of patients (in overview of all All mecanism)    pdf

liraglutide vs placebo :  Astrup (NN8022-1807 ) ,2009  - 

Test diabète

type 2 daibetes (NIDD) (in overview of all antidiabetic drugs)    pdf

LEAD-6 ext (Buse) ,2010  -  Chatterjee ,2009  -  Irie ,2008  -  LEAD 3 extension  -  NN2211-1333  -  liraglutide vs glargine add on SU+MET :  LEAD-5 (vs Glargine) (unpublished)  - 
liraglutide vs glimepiride :  Madsbad (vs Glimepiride) ,2004  -  LEAD-3 mono (Garber) ,2009  - 
liraglutide vs glimepiride add on MET :  LEAD-2 (Nauck) (vs glimepiride) ,2009  - 
liraglutide vs insulin glargine :  EAGLE (ongoing)  - 
liraglutide vs metformin :  Feinglos ,2005  -  LEAD-2 (vs MET) ,2009  - 
liraglutide vs placebo :  Vilsboll ,2008  -  Seino ,2008  -  Madsbad (vs placebo) ,2004  -  NN2211-3533  -  LIBRA (ongoing)  -  NN2211-1800 (ongoing)  -  NN2211-3534  -  NN2211-3619 (ongoing)  -  NN8022-1923 (ongoing)  -  NN8022-1922 (ongoing)  - 
liraglutide vs placebo add on MET :  LEAD-2 (Nauck) (vs placebo) ,2009  -  NCT01234649 (ongoing)  - 
liraglutide vs placebo add on SU :  LEAD-1 (unpublished)  - 
liraglutide vs placebo add on SU+MET :  LEAD-5 (vs placebo) (unpublished)  - 
liraglutide vs placebo add on TZD+MET :  LEAD-4 (unpublished)  - 
liraglutide vs sitagliptin add on MET :  MK-0431-403 (ongoing)  - 
liraglutide vs sitagliptine add on MET :  LEADER (ongoing)  - 

Entry terms: victoza, liraglutide, victoza, NN 2211, NN2211, NN-2211

See also relatic topics:

• insulin secretagogues peptides (incretins)
• insulin secretagogues peptides (incretins) in diabetes
• clinical trials of liraglutide
• clinical trials of victoza

Search liraglutide clinical trials in Pubmed

Search liraglutide clinical trials in ClinicalTrials.gov

Search liraglutide clinical trials in Wikipedia

Search liraglutide in drugs.com

browse_trt3

This site complies to the HONcode standard for trustworthy health information: verify here.

Last uptaded on 2011/4 105 user(s) connected

TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .

OpenSearch feed - Add TrialResults-center.org to your browser's search bar